CoChat

Residual Corticosteroid Production in Autoimmune Addison Disease

Open access
Sævik, Åse Bjorvatn, Åkerman, Anna-Karin, Methlie, Paal, Quinkler, Marcus, Jørgensen, Anders Palmstrøm, Höybye, Charlotte, Debowska, Aleksandra J, Nedrebø, Bjørn Gunnar, Dahle, Anne Lise, Carlsen, Siri, Tomkowicz, Aneta, Sollid, Stina Therese, Nermoen, Ingrid, Grønning, Kaja, Dahlqvist, Per, Grimnes, Guri, Skov, Jakob, Finnes, Trine, Valland, Susanna F, Wahlberg, Jeanette, Holte, Synnøve Emblem, Simunkova, Katerina, Kämpe, Olle, Husebye, Eystein Sverre, Bensing, Sophie, øksnes, Marianne · 2020 · The Journal of Clinical Endocrinology & Metabolism
Cited by 28

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Context: Contrary to current dogma, growing evidence suggests that some patients with autoimmune Addison disease (AAD) produce corticosteroids even years after diagnosis. Objective: To determine frequencies and clinical features of residual corticosteroid production in patients with AAD. Design: Two-staged, cross-sectional clinical study in 17 centers (Norway, Sweden, and Germany). Residual glucocorticoid (GC) production was defined as quantifiable serum cortisol and 11-deoxycortisol and residual mineralocorticoid (MC) production as quantifiable serum aldosterone and corticosterone after > 18 hours of medication fasting. Corticosteroids were analyzed by liquid chromatography–tandem mass spectrometry. Clinical variables included frequency of adrenal crises and quality of life. Peak cortisol response was evaluated by a standard 250 µg cosyntropin test. Results: Fifty-eight (30.2%) of 192 patients had residual GC production, more common in men (n = 33; P < 0.002) and in shorter disease duration (median 6 [0-44] vs 13 [0-53] years; P < 0.001). Residual MC production was found in 26 (13.5%) patients and associated with shorter disease duration (median 5.5 [0.5-26.0] vs 13 [0-53] years; P < 0.004), lower fludrocortisone replacement dosage (median 0.075 [0.050-0.120] vs 0.100 [0.028-0.300] mg; P < 0.005), and higher plasma renin concentration (median 179 [22-915] vs 47.5 [0.6-658.0] mU/L; P < 0.001). There was no significant association between residual production and frequency of adrenal crises or quality of life. None had a normal cosyntropin response, but peak cortisol strongly correlated with unstimulated cortisol (r = 0.989; P < 0.001) and plasma adrenocorticotropic hormone (ACTH; r = –0.487; P < 0.001). Conclusion: In established AAD, one-third of the patients still produce GCs even decades after diagnosis. Residual production is more common in men and in patients with shorter disease duration but is not associated with adrenal crises or quality of life.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/clinem/dgaa256

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

Metadata

Authors
Sævik, Å. B., Åkerman, A.-K., Methlie, P., Quinkler, M., Jørgensen, A. P., Höybye, C., Debowska, A. J., Nedrebø, B. G., Dahle, A. L., Carlsen, S., Tomkowicz, A., Sollid, S. T., Nermoen, I., Grønning, K., Dahlqvist, P., Grimnes, G., Skov, J., Finnes, T., Valland, S. F., Wahlberg, J., Holte, S. E., Simunkova, K., Kämpe, O., Husebye, E. S., Bensing, S., & øksnes, M.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2020-05-11
Volume
105
Issue
7
Pages
2430-2441
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W3022077104
Cited by
28
References
13
FWCI
2.71
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.